Request for Covid-19 Impact Assessment of this Report
The United States Drug Eluting Stents(DES) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug Eluting Stents(DES) market, reaching US$ million by the year 2028. As for the Europe Drug Eluting Stents(DES) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug Eluting Stents(DES) players cover Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, and Biosensors, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Stents(DES) market by product type, application, key manufacturers and key regions and countries.
Segmentation by materials: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Coronary Heart Disease
Clinical
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Eluting Stents(DES) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug Eluting Stents(DES) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug Eluting Stents(DES) by Country/Region, 2017, 2022 & 2028
2.2 Drug Eluting Stents(DES) Segment by Materials
2.2.1 Cobalt-chromium Alloy Stents
2.2.2 Magnesium Alloy Stents
2.2.3 Tyrosine Polycarbonate Stents
2.2.4 Nitinol Stents
2.2.5 Platinum Chromium Alloy Stents
2.2.6 Stainless Steel Stents
2.2.7 Other Materials
2.3 Drug Eluting Stents(DES) Sales by Materials
2.3.1 Global Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
2.3.2 Global Drug Eluting Stents(DES) Revenue and Market Share by Materials (2017-2022)
2.3.3 Global Drug Eluting Stents(DES) Sale Price by Materials (2017-2022)
2.4 Drug Eluting Stents(DES) Segment by Application
2.4.1 Coronary Heart Disease
2.4.2 Clinical
2.5 Drug Eluting Stents(DES) Sales by Application
2.5.1 Global Drug Eluting Stents(DES) Sale Market Share by Application (2017-2022)
2.5.2 Global Drug Eluting Stents(DES) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug Eluting Stents(DES) Sale Price by Application (2017-2022)
3 Global Drug Eluting Stents(DES) by Company
3.1 Global Drug Eluting Stents(DES) Breakdown Data by Company
3.1.1 Global Drug Eluting Stents(DES) Annual Sales by Company (2020-2022)
3.1.2 Global Drug Eluting Stents(DES) Sales Market Share by Company (2020-2022)
3.2 Global Drug Eluting Stents(DES) Annual Revenue by Company (2020-2022)
3.2.1 Global Drug Eluting Stents(DES) Revenue by Company (2020-2022)
3.2.2 Global Drug Eluting Stents(DES) Revenue Market Share by Company (2020-2022)
3.3 Global Drug Eluting Stents(DES) Sale Price by Company
3.4 Key Manufacturers Drug Eluting Stents(DES) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Stents(DES) Product Location Distribution
3.4.2 Players Drug Eluting Stents(DES) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drug Eluting Stents(DES) by Geographic Region
4.1 World Historic Drug Eluting Stents(DES) Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug Eluting Stents(DES) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug Eluting Stents(DES) Annual Revenue by Geographic Region
4.2 World Historic Drug Eluting Stents(DES) Market Size by Country/Region (2017-2022)
4.2.1 Global Drug Eluting Stents(DES) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug Eluting Stents(DES) Annual Revenue by Country/Region
4.3 Americas Drug Eluting Stents(DES) Sales Growth
4.4 APAC Drug Eluting Stents(DES) Sales Growth
4.5 Europe Drug Eluting Stents(DES) Sales Growth
4.6 Middle East & Africa Drug Eluting Stents(DES) Sales Growth
5 Americas
5.1 Americas Drug Eluting Stents(DES) Sales by Country
5.1.1 Americas Drug Eluting Stents(DES) Sales by Country (2017-2022)
5.1.2 Americas Drug Eluting Stents(DES) Revenue by Country (2017-2022)
5.2 Americas Drug Eluting Stents(DES) Sales by Materials
5.3 Americas Drug Eluting Stents(DES) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Stents(DES) Sales by Region
6.1.1 APAC Drug Eluting Stents(DES) Sales by Region (2017-2022)
6.1.2 APAC Drug Eluting Stents(DES) Revenue by Region (2017-2022)
6.2 APAC Drug Eluting Stents(DES) Sales by Materials
6.3 APAC Drug Eluting Stents(DES) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug Eluting Stents(DES) by Country
7.1.1 Europe Drug Eluting Stents(DES) Sales by Country (2017-2022)
7.1.2 Europe Drug Eluting Stents(DES) Revenue by Country (2017-2022)
7.2 Europe Drug Eluting Stents(DES) Sales by Materials
7.3 Europe Drug Eluting Stents(DES) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Eluting Stents(DES) by Country
8.1.1 Middle East & Africa Drug Eluting Stents(DES) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug Eluting Stents(DES) Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug Eluting Stents(DES) Sales by Materials
8.3 Middle East & Africa Drug Eluting Stents(DES) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Stents(DES)
10.3 Manufacturing Process Analysis of Drug Eluting Stents(DES)
10.4 Industry Chain Structure of Drug Eluting Stents(DES)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Stents(DES) Distributors
11.3 Drug Eluting Stents(DES) Customer
12 World Forecast Review for Drug Eluting Stents(DES) by Geographic Region
12.1 Global Drug Eluting Stents(DES) Market Size Forecast by Region
12.1.1 Global Drug Eluting Stents(DES) Forecast by Region (2023-2028)
12.1.2 Global Drug Eluting Stents(DES) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Stents(DES) Forecast by Materials
12.7 Global Drug Eluting Stents(DES) Forecast by Application
13 Key Players Analysis
13.1 Abbott Vascular
13.1.1 Abbott Vascular Company Information
13.1.2 Abbott Vascular Drug Eluting Stents(DES) Product Offered
13.1.3 Abbott Vascular Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Vascular Main Business Overview
13.1.5 Abbott Vascular Latest Developments
13.2 Advantec Vascular
13.2.1 Advantec Vascular Company Information
13.2.2 Advantec Vascular Drug Eluting Stents(DES) Product Offered
13.2.3 Advantec Vascular Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Advantec Vascular Main Business Overview
13.2.5 Advantec Vascular Latest Developments
13.3 B.Braun Melsengen AG
13.3.1 B.Braun Melsengen AG Company Information
13.3.2 B.Braun Melsengen AG Drug Eluting Stents(DES) Product Offered
13.3.3 B.Braun Melsengen AG Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 B.Braun Melsengen AG Main Business Overview
13.3.5 B.Braun Melsengen AG Latest Developments
13.4 Biosensors
13.4.1 Biosensors Company Information
13.4.2 Biosensors Drug Eluting Stents(DES) Product Offered
13.4.3 Biosensors Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biosensors Main Business Overview
13.4.5 Biosensors Latest Developments
13.5 Biotronik
13.5.1 Biotronik Company Information
13.5.2 Biotronik Drug Eluting Stents(DES) Product Offered
13.5.3 Biotronik Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biotronik Main Business Overview
13.5.5 Biotronik Latest Developments
13.6 Blue Medical
13.6.1 Blue Medical Company Information
13.6.2 Blue Medical Drug Eluting Stents(DES) Product Offered
13.6.3 Blue Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Blue Medical Main Business Overview
13.6.5 Blue Medical Latest Developments
13.7 Boston Scientific
13.7.1 Boston Scientific Company Information
13.7.2 Boston Scientific Drug Eluting Stents(DES) Product Offered
13.7.3 Boston Scientific Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Boston Scientific Main Business Overview
13.7.5 Boston Scientific Latest Developments
13.8 DISA Vascular
13.8.1 DISA Vascular Company Information
13.8.2 DISA Vascular Drug Eluting Stents(DES) Product Offered
13.8.3 DISA Vascular Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 DISA Vascular Main Business Overview
13.8.5 DISA Vascular Latest Developments
13.9 Essen
13.9.1 Essen Company Information
13.9.2 Essen Drug Eluting Stents(DES) Product Offered
13.9.3 Essen Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Essen Main Business Overview
13.9.5 Essen Latest Developments
13.10 Medtronic Vascular
13.10.1 Medtronic Vascular Company Information
13.10.2 Medtronic Vascular Drug Eluting Stents(DES) Product Offered
13.10.3 Medtronic Vascular Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Medtronic Vascular Main Business Overview
13.10.5 Medtronic Vascular Latest Developments
13.11 MicroPort Medical
13.11.1 MicroPort Medical Company Information
13.11.2 MicroPort Medical Drug Eluting Stents(DES) Product Offered
13.11.3 MicroPort Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 MicroPort Medical Main Business Overview
13.11.5 MicroPort Medical Latest Developments
13.12 MIV Therapeutics
13.12.1 MIV Therapeutics Company Information
13.12.2 MIV Therapeutics Drug Eluting Stents(DES) Product Offered
13.12.3 MIV Therapeutics Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 MIV Therapeutics Main Business Overview
13.12.5 MIV Therapeutics Latest Developments
13.13 Orbusneich
13.13.1 Orbusneich Company Information
13.13.2 Orbusneich Drug Eluting Stents(DES) Product Offered
13.13.3 Orbusneich Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Orbusneich Main Business Overview
13.13.5 Orbusneich Latest Developments
13.14 Promed Medical
13.14.1 Promed Medical Company Information
13.14.2 Promed Medical Drug Eluting Stents(DES) Product Offered
13.14.3 Promed Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Promed Medical Main Business Overview
13.14.5 Promed Medical Latest Developments
13.15 Relisys Medical
13.15.1 Relisys Medical Company Information
13.15.2 Relisys Medical Drug Eluting Stents(DES) Product Offered
13.15.3 Relisys Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Relisys Medical Main Business Overview
13.15.5 Relisys Medical Latest Developments
13.16 Reva Medical
13.16.1 Reva Medical Company Information
13.16.2 Reva Medical Drug Eluting Stents(DES) Product Offered
13.16.3 Reva Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Reva Medical Main Business Overview
13.16.5 Reva Medical Latest Developments
13.17 Sahajanand
13.17.1 Sahajanand Company Information
13.17.2 Sahajanand Drug Eluting Stents(DES) Product Offered
13.17.3 Sahajanand Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sahajanand Main Business Overview
13.17.5 Sahajanand Latest Developments
13.18 Sino Medical
13.18.1 Sino Medical Company Information
13.18.2 Sino Medical Drug Eluting Stents(DES) Product Offered
13.18.3 Sino Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Sino Medical Main Business Overview
13.18.5 Sino Medical Latest Developments
13.19 Sorin
13.19.1 Sorin Company Information
13.19.2 Sorin Drug Eluting Stents(DES) Product Offered
13.19.3 Sorin Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Sorin Main Business Overview
13.19.5 Sorin Latest Developments
13.20 Terumo Medical
13.20.1 Terumo Medical Company Information
13.20.2 Terumo Medical Drug Eluting Stents(DES) Product Offered
13.20.3 Terumo Medical Drug Eluting Stents(DES) Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Terumo Medical Main Business Overview
13.20.5 Terumo Medical Latest Developments
14 Research Findings and Conclusion
Table 1. Drug Eluting Stents(DES) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug Eluting Stents(DES) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Cobalt-chromium Alloy Stents
Table 4. Major Players of Magnesium Alloy Stents
Table 5. Major Players of Tyrosine Polycarbonate Stents
Table 6. Major Players of Nitinol Stents
Table 7. Major Players of Platinum Chromium Alloy Stents
Table 8. Major Players of Stainless Steel Stents
Table 9. Major Players of Other Materials
Table 10. Global Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 11. Global Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
Table 12. Global Drug Eluting Stents(DES) Revenue by Materials (2017-2022) & ($ million)
Table 13. Global Drug Eluting Stents(DES) Revenue Market Share by Materials (2017-2022)
Table 14. Global Drug Eluting Stents(DES) Sale Price by Materials (2017-2022) & (USD/Unit)
Table 15. Global Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 16. Global Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Table 17. Global Drug Eluting Stents(DES) Revenue by Application (2017-2022)
Table 18. Global Drug Eluting Stents(DES) Revenue Market Share by Application (2017-2022)
Table 19. Global Drug Eluting Stents(DES) Sale Price by Application (2017-2022) & (USD/Unit)
Table 20. Global Drug Eluting Stents(DES) Sales by Company (2020-2022) & (K Units)
Table 21. Global Drug Eluting Stents(DES) Sales Market Share by Company (2020-2022)
Table 22. Global Drug Eluting Stents(DES) Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Drug Eluting Stents(DES) Revenue Market Share by Company (2020-2022)
Table 24. Global Drug Eluting Stents(DES) Sale Price by Company (2020-2022) & (USD/Unit)
Table 25. Key Manufacturers Drug Eluting Stents(DES) Producing Area Distribution and Sales Area
Table 26. Players Drug Eluting Stents(DES) Products Offered
Table 27. Drug Eluting Stents(DES) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Drug Eluting Stents(DES) Sales by Geographic Region (2017-2022) & (K Units)
Table 31. Global Drug Eluting Stents(DES) Sales Market Share Geographic Region (2017-2022)
Table 32. Global Drug Eluting Stents(DES) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Drug Eluting Stents(DES) Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Drug Eluting Stents(DES) Sales by Country/Region (2017-2022) & (K Units)
Table 35. Global Drug Eluting Stents(DES) Sales Market Share by Country/Region (2017-2022)
Table 36. Global Drug Eluting Stents(DES) Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Drug Eluting Stents(DES) Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 39. Americas Drug Eluting Stents(DES) Sales Market Share by Country (2017-2022)
Table 40. Americas Drug Eluting Stents(DES) Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2022)
Table 42. Americas Drug Eluting Stents(DES) Sales by Type (2017-2022) & (K Units)
Table 43. Americas Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
Table 44. Americas Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 45. Americas Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Table 46. APAC Drug Eluting Stents(DES) Sales by Region (2017-2022) & (K Units)
Table 47. APAC Drug Eluting Stents(DES) Sales Market Share by Region (2017-2022)
Table 48. APAC Drug Eluting Stents(DES) Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Drug Eluting Stents(DES) Revenue Market Share by Region (2017-2022)
Table 50. APAC Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 51. APAC Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
Table 52. APAC Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 53. APAC Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Table 54. Europe Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 55. Europe Drug Eluting Stents(DES) Sales Market Share by Country (2017-2022)
Table 56. Europe Drug Eluting Stents(DES) Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2022)
Table 58. Europe Drug Eluting Stents(DES) Sales by Type (2017-2022) & (K Units)
Table 59. Europe Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
Table 60. Europe Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 61. Europe Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 63. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Drug Eluting Stents(DES) Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 67. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2022)
Table 68. Middle East & Africa Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Drug Eluting Stents(DES)
Table 71. Key Market Challenges & Risks of Drug Eluting Stents(DES)
Table 72. Key Industry Trends of Drug Eluting Stents(DES)
Table 73. Drug Eluting Stents(DES) Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Drug Eluting Stents(DES) Distributors List
Table 76. Drug Eluting Stents(DES) Customer List
Table 77. Global Drug Eluting Stents(DES) Sales Forecast by Region (2023-2028) & (K Units)
Table 78. Global Drug Eluting Stents(DES) Sales Market Forecast by Region
Table 79. Global Drug Eluting Stents(DES) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Drug Eluting Stents(DES) Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Americas Drug Eluting Stents(DES) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Drug Eluting Stents(DES) Sales Forecast by Region (2023-2028) & (K Units)
Table 84. APAC Drug Eluting Stents(DES) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Drug Eluting Stents(DES) Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Europe Drug Eluting Stents(DES) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Drug Eluting Stents(DES) Sales Forecast by Country (2023-2028) & (K Units)
Table 88. Middle East & Africa Drug Eluting Stents(DES) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Drug Eluting Stents(DES) Sales Forecast by Materials (2023-2028) & (K Units)
Table 90. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Materials (2023-2028)
Table 91. Global Drug Eluting Stents(DES) Revenue Forecast by Materials (2023-2028) & ($ Millions)
Table 92. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Materials (2023-2028)
Table 93. Global Drug Eluting Stents(DES) Sales Forecast by Application (2023-2028) & (K Units)
Table 94. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Drug Eluting Stents(DES) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Drug Eluting Stents(DES) Revenue Market Share Forecast by Application (2023-2028)
Table 97. Abbott Vascular Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Vascular Drug Eluting Stents(DES) Product Offered
Table 99. Abbott Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Abbott Vascular Main Business
Table 101. Abbott Vascular Latest Developments
Table 102. Advantec Vascular Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 103. Advantec Vascular Drug Eluting Stents(DES) Product Offered
Table 104. Advantec Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Advantec Vascular Main Business
Table 106. Advantec Vascular Latest Developments
Table 107. B.Braun Melsengen AG Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 108. B.Braun Melsengen AG Drug Eluting Stents(DES) Product Offered
Table 109. B.Braun Melsengen AG Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. B.Braun Melsengen AG Main Business
Table 111. B.Braun Melsengen AG Latest Developments
Table 112. Biosensors Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 113. Biosensors Drug Eluting Stents(DES) Product Offered
Table 114. Biosensors Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Biosensors Main Business
Table 116. Biosensors Latest Developments
Table 117. Biotronik Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 118. Biotronik Drug Eluting Stents(DES) Product Offered
Table 119. Biotronik Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Biotronik Main Business
Table 121. Biotronik Latest Developments
Table 122. Blue Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 123. Blue Medical Drug Eluting Stents(DES) Product Offered
Table 124. Blue Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Blue Medical Main Business
Table 126. Blue Medical Latest Developments
Table 127. Boston Scientific Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 128. Boston Scientific Drug Eluting Stents(DES) Product Offered
Table 129. Boston Scientific Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Boston Scientific Main Business
Table 131. Boston Scientific Latest Developments
Table 132. DISA Vascular Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 133. DISA Vascular Drug Eluting Stents(DES) Product Offered
Table 134. DISA Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. DISA Vascular Main Business
Table 136. DISA Vascular Latest Developments
Table 137. Essen Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 138. Essen Drug Eluting Stents(DES) Product Offered
Table 139. Essen Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Essen Main Business
Table 141. Essen Latest Developments
Table 142. Medtronic Vascular Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 143. Medtronic Vascular Drug Eluting Stents(DES) Product Offered
Table 144. Medtronic Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Medtronic Vascular Main Business
Table 146. Medtronic Vascular Latest Developments
Table 147. MicroPort Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 148. MicroPort Medical Drug Eluting Stents(DES) Product Offered
Table 149. MicroPort Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. MicroPort Medical Main Business
Table 151. MicroPort Medical Latest Developments
Table 152. MIV Therapeutics Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 153. MIV Therapeutics Drug Eluting Stents(DES) Product Offered
Table 154. MIV Therapeutics Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. MIV Therapeutics Main Business
Table 156. MIV Therapeutics Latest Developments
Table 157. Orbusneich Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 158. Orbusneich Drug Eluting Stents(DES) Product Offered
Table 159. Orbusneich Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Orbusneich Main Business
Table 161. Orbusneich Latest Developments
Table 162. Promed Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 163. Promed Medical Drug Eluting Stents(DES) Product Offered
Table 164. Promed Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Promed Medical Main Business
Table 166. Promed Medical Latest Developments
Table 167. Relisys Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 168. Relisys Medical Drug Eluting Stents(DES) Product Offered
Table 169. Relisys Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. Relisys Medical Main Business
Table 171. Relisys Medical Latest Developments
Table 172. Reva Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 173. Reva Medical Drug Eluting Stents(DES) Product Offered
Table 174. Reva Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Reva Medical Main Business
Table 176. Reva Medical Latest Developments
Table 177. Sahajanand Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 178. Sahajanand Drug Eluting Stents(DES) Product Offered
Table 179. Sahajanand Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 180. Sahajanand Main Business
Table 181. Sahajanand Latest Developments
Table 182. Sino Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 183. Sino Medical Drug Eluting Stents(DES) Product Offered
Table 184. Sino Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 185. Sino Medical Main Business
Table 186. Sino Medical Latest Developments
Table 187. Sorin Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 188. Sorin Drug Eluting Stents(DES) Product Offered
Table 189. Sorin Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 190. Sorin Main Business
Table 191. Sorin Latest Developments
Table 192. Terumo Medical Basic Information, Drug Eluting Stents(DES) Manufacturing Base, Sales Area and Its Competitors
Table 193. Terumo Medical Drug Eluting Stents(DES) Product Offered
Table 194. Terumo Medical Drug Eluting Stents(DES) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 195. Terumo Medical Main Business
Table 196. Terumo Medical Latest Developments
List of Figures
Figure 1. Picture of Drug Eluting Stents(DES)
Figure 2. Drug Eluting Stents(DES) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Stents(DES) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug Eluting Stents(DES) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug Eluting Stents(DES) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Cobalt-chromium Alloy Stents
Figure 10. Product Picture of Magnesium Alloy Stents
Figure 11. Product Picture of Tyrosine Polycarbonate Stents
Figure 12. Product Picture of Nitinol Stents
Figure 13. Product Picture of Platinum Chromium Alloy Stents
Figure 14. Product Picture of Stainless Steel Stents
Figure 15. Product Picture of Other Materials
Figure 16. Global Drug Eluting Stents(DES) Sales Market Share by Materials in 2021
Figure 17. Global Drug Eluting Stents(DES) Revenue Market Share by Materials (2017-2022)
Figure 18. Drug Eluting Stents(DES) Consumed in Coronary Heart Disease
Figure 19. Global Drug Eluting Stents(DES) Market: Coronary Heart Disease (2017-2022) & (K Units)
Figure 20. Drug Eluting Stents(DES) Consumed in Clinical
Figure 21. Global Drug Eluting Stents(DES) Market: Clinical (2017-2022) & (K Units)
Figure 22. Global Drug Eluting Stents(DES) Sales Market Share by Application (2017-2022)
Figure 23. Global Drug Eluting Stents(DES) Revenue Market Share by Application in 2021
Figure 24. Drug Eluting Stents(DES) Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Drug Eluting Stents(DES) Revenue Market Share by Company in 2021
Figure 26. Global Drug Eluting Stents(DES) Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Drug Eluting Stents(DES) Revenue Market Share by Geographic Region in 2021
Figure 28. Global Drug Eluting Stents(DES) Sales Market Share by Region (2017-2022)
Figure 29. Global Drug Eluting Stents(DES) Revenue Market Share by Country/Region in 2021
Figure 30. Americas Drug Eluting Stents(DES) Sales 2017-2022 (K Units)
Figure 31. Americas Drug Eluting Stents(DES) Revenue 2017-2022 ($ Millions)
Figure 32. APAC Drug Eluting Stents(DES) Sales 2017-2022 (K Units)
Figure 33. APAC Drug Eluting Stents(DES) Revenue 2017-2022 ($ Millions)
Figure 34. Europe Drug Eluting Stents(DES) Sales 2017-2022 (K Units)
Figure 35. Europe Drug Eluting Stents(DES) Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Drug Eluting Stents(DES) Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Drug Eluting Stents(DES) Revenue 2017-2022 ($ Millions)
Figure 38. Americas Drug Eluting Stents(DES) Sales Market Share by Country in 2021
Figure 39. Americas Drug Eluting Stents(DES) Revenue Market Share by Country in 2021
Figure 40. United States Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Drug Eluting Stents(DES) Sales Market Share by Region in 2021
Figure 45. APAC Drug Eluting Stents(DES) Revenue Market Share by Regions in 2021
Figure 46. China Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Drug Eluting Stents(DES) Sales Market Share by Country in 2021
Figure 53. Europe Drug Eluting Stents(DES) Revenue Market Share by Country in 2021
Figure 54. Germany Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Drug Eluting Stents(DES) Revenue Market Share by Country in 2021
Figure 61. Egypt Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Drug Eluting Stents(DES) Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Drug Eluting Stents(DES) in 2021
Figure 67. Manufacturing Process Analysis of Drug Eluting Stents(DES)
Figure 68. Industry Chain Structure of Drug Eluting Stents(DES)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...